finance.foundation / Companies / Eli Lilly (LLY)
Company · Healthcare · Pharmaceuticals
Eli Lilly (LLY)
Pharmaceutical maker; GLP-1 metabolic drugs (Mounjaro, Zepbound), oncology and neuroscience.
- Legal name
- Eli Lilly and Company
- Ticker
- LLY
- Exchange
- New York Stock Exchange · MIC XNYS
- Country
- United States
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Market cap ≈
- $750bn (approx., seed-0.6 · 2026-08-29)
- Reporting currency
- USD
- Founded
- 1876
- Website
- www.lilly.com
- LEI
- FRDRIPF3EKNDJ2CQJL29 (GLEIF)
- ISIN
- US5324571083 (check digit validated)
- FIGI
- BBG001S5STL8 (share class, OpenFIGI)
Graph connections view in graph →
lists_onNew York Stock Exchange
domiciled_inUnited States
member_ofS&P 500
held_by (top holdings)iShares Core MSCI World UCITS ETF
Sector peers — Healthcare
Compare: LLY vs UNH · LLY vs JNJ · LLY vs ABBV
Identifier crosswalk
| Standard | Value | What it answers |
|---|---|---|
| Ticker | LLY | Venue-local shorthand — ambiguous across markets |
| MIC | XNYS | ISO 10383 — the venue |
| ISIN | US5324571083 | ISO 6166 — the security |
| LEI | FRDRIPF3EKNDJ2CQJL29 | ISO 17442 — the legal entity |
| FIGI | BBG001S5STL8 | OpenFIGI — instrument, share class |
| CUSIP | 532457108 | Derived from the US/CA ISIN, check digit verified — licensed identifier, not republished as data |
One entity, six naming systems. Each linked code opens its reverse-lookup page; the validator checks any code's check digit. CUSIP is shown because it is embedded in US/CA ISINs — we verify it, we do not redistribute CUSIP data.
Approximate reference values from public sources · seed-0.6 · 2026-08-29 · not real-time. See data & methodology.
# this page as data
GET https://finance.foundation/api/v1/companies/eli-lilly